Y-27632 dihydrochloride 

To Order Contact us: stephen@expresspharmapulse.com

Y-27632 dihydrochloride
A3008-200 200 mg
EUR 1284
Description: Y-27632 dihydrochloride is a small-molecule inhibitor of Rho-associated protein kinase p160ROCK with the IC50 of 140 nM. Y-27632 suppresses the kinase activity of both ROCK-1 and ROCK-2 in vitro, and this compound inhibits the kinases by binding to the catalytic site of ROCK-1 and ROCK-2.

Y-27632 dihydrochloride
A3008-5.1 10 mM (in 1mL DMSO)
EUR 177.6
Description: Y-27632 dihydrochloride is a small-molecule inhibitor of Rho-associated protein kinase p160ROCK with the IC50 of 140 nM. Y-27632 suppresses the kinase activity of both ROCK-1 and ROCK-2 in vitro, and this compound inhibits the kinases by binding to the catalytic site of ROCK-1 and ROCK-2.

Y-27632 dihydrochloride
A3008-50 50 mg
EUR 505.2
Description: Y-27632 dihydrochloride is a small-molecule inhibitor of Rho-associated protein kinase p160ROCK with the IC50 of 140 nM. Y-27632 suppresses the kinase activity of both ROCK-1 and ROCK-2 in vitro, and this compound inhibits the kinases by binding to the catalytic site of ROCK-1 and ROCK-2.

Y-27632 dihydrochloride
GK8578-1MG 1 mg
EUR 170.4

Y-27632 dihydrochloride
GK8578-25MG 25 mg
EUR 945.6

Y-27632 dihydrochloride
GK8578-5MG 5 mg
EUR 399.6

Y-27632 (dihydrochloride)
HY-10583 50mg
EUR 349.2

Y-27632
E1KS1049 2 mg
EUR 390

Y 27632
20-abx076548
  • EUR 326.40
  • EUR 627.60
  • 1 mg
  • 5 mg

Y-27632
B1293-10 10 mg
EUR 170.4
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Y-27632
B1293-200 200 mg
EUR 1284
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Y-27632
B1293-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Y-27632
B1293-50 50 mg
EUR 505.2
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Y-27632
HY-10071 100mg
EUR 1480.8

EZSolution? Y-27632
1784-5
EUR 535.2

EZSolution? Y-27632, Sterile-Filtered
1994-1
EUR 430.8

Y 27632 (ROCK kinase inhibitor)
SIH-486-1MG 1 mg
EUR 178.8
Description: The substance Y 27632 is a rock kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to pale yellow powder which is soluble in DMSO (25 mg/ml), methanol (25 mg/ml), acetonitrile (<1 mg/ml), dioxan (<1 mg/ml), water (very soluble.

Y 27632 (ROCK kinase inhibitor)
SIH-486-5MG 5 mg
EUR 393.6
Description: The substance Y 27632 is a rock kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to pale yellow powder which is soluble in DMSO (25 mg/ml), methanol (25 mg/ml), acetonitrile (<1 mg/ml), dioxan (<1 mg/ml), water (very soluble.

Y-39983 dihydrochloride
B1176-10 10 mg
EUR 494.4
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1].

Y-39983 dihydrochloride
B1176-100 100 mg
EUR 2881.2
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1].

Y-39983 dihydrochloride
B1176-5 5 mg
EUR 320.4
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1].

Y-39983 dihydrochloride
B1176-50 50 mg
EUR 1796.4
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1].

Y-33075 (dihydrochloride)
HY-10069 5mg
EUR 258

SNRPF Polyclonal Antibody
27632-100ul 100ul
EUR 302.4

SNRPF Polyclonal Antibody
27632-50ul 50ul
EUR 224.4

Cefotiam Dihydrochloride
C095-100MG 100 mg
EUR 278.4

Cefotiam Dihydrochloride
C095-50MG 50 mg
EUR 172.8

Chlorhexidine Dihydrochloride
C157-25G 25 g
EUR 222

Chlorhexidine Dihydrochloride
C157-5G 5 g
EUR 86.4

Retigabine dihydrochloride
A3758-10 10 mg
EUR 164.4
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride
A3758-100 100 mg
EUR 522
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride
A3758-5 5 mg
EUR 126
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride
A3758-5.1 10 mM (in 1mL DMSO)
EUR 170.4
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride
A3758-50 50 mg
EUR 325.2
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Veliparib dihydrochloride
A3958-10 10 mg
EUR 177.6
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride
A3958-200 200 mg
EUR 1002
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride
A3958-5 5 mg
EUR 150
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride
A3958-5.1 10 mM (in 1mL DMSO)
EUR 139.2
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride
A3958-50 50 mg
EUR 421.2
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Ethambutol dihydrochloride
E005-100G 100 g
EUR 508.8

Ethambutol dihydrochloride
E005-25G 25 g
EUR 171.6

Antipain, dihydrochloride
ADJ692 5mg
EUR 110.53

Naftopidil Dihydrochloride
E1KS1387 25mg
EUR 296.4

Norquetiapine dihydrochloride
2362-250
EUR 496.8

Norquetiapine dihydrochloride
2362-50
EUR 170.4

1400W dihydrochloride
2055-25
EUR 405.6

1400W dihydrochloride
2055-5
EUR 151.2

GGACK Dihydrochloride
1847-5 5 mg
EUR 382.8
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin.

PPACK Dihydrochloride
1848-5
EUR 301.2

Puromycin Dihydrochloride
1860-100
EUR 326.4

Puromycin Dihydrochloride
1860-1000
EUR 1554

Puromycin Dihydrochloride
1860-25
EUR 151.2

Puromycin Dihydrochloride
1860-250
EUR 548.4

Puromycin Dihydrochloride
1860-500
EUR 966

Emetine dihydrochloride
1970-250
EUR 430.8

Emetine dihydrochloride
1970-50
EUR 164.4

Berbamine dihydrochloride
2520-100
EUR 157.2

Berbamine dihydrochloride
2520-500
EUR 444

Vatalanib Dihydrochloride
2025-25
EUR 366

Vatalanib Dihydrochloride
2025-5
EUR 151.2

Antipain dihydrochloride
2834-25
EUR 392.4

Antipain dihydrochloride
2834-5
EUR 144

Dorsmorphin dihydrochloride
2835-25
EUR 705.6

Dorsmorphin dihydrochloride
2835-5
EUR 222

AT7867 dihydrochloride
A3199-10 10 mg
EUR 408
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

Y-27632 dihydrochloride